Teva Pharmaceutical Industries Limited (TEVA)
NYSE: TEVA · Real-Time Price · USD
30.81
-0.37 (-1.19%)
At close: Jul 24, 2026, 4:00 PM EDT
30.91
+0.10 (0.31%)
After-hours: Jul 24, 2026, 7:34 PM EDT

Teva Pharmaceutical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jul '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
35,87635,88624,99011,70410,1328,838
Market Cap Growth
88.66%43.60%113.51%15.51%14.65%-16.48%
Enterprise Value
49,06049,42840,11629,25129,68631,098
Last Close Price
30.8131.2122.0410.449.128.01
PE Ratio
23.0125.79---21.08
Forward PE
14.6312.078.354.213.633.02
PEG Ratio
2.651.826.690.401.630.68
PS Ratio
2.072.081.510.740.680.56
PB Ratio
4.364.544.651.561.300.86
P/FCF Ratio
30.6131.2633.3613.909.7237.45
P/OCF Ratio
20.9321.7620.048.566.3711.07
EV/Sales Ratio
2.832.862.421.851.991.96
EV/EBITDA Ratio
14.9215.6553.0618.44-10.21
EV/EBIT Ratio
21.4322.92-67.55-18.13
EV/FCF Ratio
41.8643.0653.5634.7428.49131.77
Debt / Equity Ratio
2.052.163.162.482.512.09
Debt / EBITDA Ratio
5.145.4123.9112.71-7.70
Debt / FCF Ratio
14.4314.8924.1423.9420.6999.40
Net Debt / Equity Ratio
1.601.712.752.262.402.07
Net Debt / EBITDA Ratio
4.004.2919.5510.67-21.106.99
Net Debt / FCF Ratio
11.2311.7919.7320.1018.0090.23
Asset Turnover
0.430.430.400.360.330.32
Inventory Turnover
2.622.692.412.092.082.02
Quick Ratio
0.530.540.500.540.570.61
Current Ratio
1.011.040.981.021.051.14
Return on Equity (ROE)
19.22%20.58%-28.31%-7.38%-25.40%4.01%
Return on Assets (ROA)
6.44%6.18%-1.12%0.98%-3.82%2.37%
Return on Invested Capital (ROIC)
12.14%11.80%-2.03%1.63%-5.85%3.44%
Return on Capital Employed (ROCE)
8.51%8.02%-1.05%1.36%-6.35%4.63%
Earnings Yield
4.36%3.88%---4.74%
FCF Yield
3.27%3.20%3.00%7.19%10.28%2.67%
Buyback Yield / Dilution
-2.93%-2.83%-1.07%-0.81%-0.27%-1.10%
Total Shareholder Return
-2.93%-2.83%-1.07%-0.81%-0.27%-1.10%
SEC Filings: 10-K · 10-Q